Pharmacokinetics of Tiotropium in Subjects With COPD

Study Title
To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Teva Identifier
TBB-COPD-201
ClinicalTrials.gov Identifier
NCT01785433
Study Status
Completed
Trial Condition(s)
COPD
Interventions
Drug: Tiotropium HFA BAI 4.5 mcg | Drug: Tiotropium HFA BAI 9.0 mcg | Drug: SPIRIVAֲ® HandiHalerֲ® 18 mcg/day | Drug: Spirivaֲ® Respimatֲ® 5 mcg/day

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
40 Years to 80 Years
Trial Duration
01/01/2013 - 08/01/2013
Phase
Phase 1/2

Study Type

Interventional